Abivax (ABVX) Non Operating Income (2024 - 2026)

Abivax's Non Operating Income history runs 3 years deep, the most recent figure standing at $9.4 million for Q1 2026.

• On a quarterly basis, Non Operating Income rose 271.99% year-over-year to $9.4 million in Q1 2026; TTM through Mar 2026 was -$82.9 million, a 649.4% decrease from a year earlier, with the FY2025 full-year figure at -$98.0 million, down 2644.13% from the prior year.
• Non Operating Income improved to $9.4 million in Q1 2026 per ABVX's latest filing, from -$5.2 million in the prior quarter.
• Across five years, Non Operating Income topped out at $9.4 million in Q1 2026 and bottomed at -$84.9 million in Q3 2025.
• The 3-year median for Non Operating Income is -$3.7 million (2024), against an average of -$10.2 million.
• Across the five-year window, Non Operating Income plunged 1435.29% in 2025 and jumped 271.99% in 2026, its largest moves.
• Year by year, Non Operating Income stood at $3.6 million in 2024, then plunged by 243.94% to -$5.2 million in 2025, then jumped by 279.96% to $9.4 million in 2026.
• Per Business Quant, the three latest ABVX Non Operating Income figures stand at $9.4 million (Q1 2026), -$5.2 million (Q4 2025), and -$84.9 million (Q3 2025).